4893.T
Noile-Immune Biotech Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 147.00
+0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-20.2%
Return on equity
-19.8%
Return on assets
-20.3%
Return on invested capital
0.00x
Asset turnover
-JPY 752.0M
Cash from operations
JPY 90
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026